Liberty Wealth Management LLC Global Blood Therapeutics, Inc. Transaction History

Liberty Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$24.9 - $40.26 $1,992 - $3,220	-80 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$32.46 - $43.42 $88,356 - $118,189	-2,722 Reduced 97.14%	80 $3,000
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $88,356 - $118,189	2,722 Added 3402.5%	2,802 $80,000
Q2 2020 Aug 04, 2020	BUY	$48.73 - $81.82 $3,898 - $6,545	80 New	80 $5,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty Wealth Management LLC with notifications on news.